Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
GenMont Biotech financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

NT$21

2024-10-29

Market Capitalization

NT$1.8 B

2024-10-29

Revenue

NT$401.2 M

FY, 2025

CreditSafe Score

?
Score changed on Jul 23, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

TWDFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue406.5M346.2M325.2M427.9M368.5M318.0M385.4M401.2M
Cost of goods sold101.9M95.3M88.9M107.5M61.4M42.0M75.6M82.6M
Gross profit308.7M252.4M244.5M321.6M307.1M276.0M309.8M318.6M
Gross profit margin, %75.9%72.9%75.2%75.2%83.3%86.8%80.4%79.4%
Operating expense total155.3M152.9M145.0M171.0M196.5M203.5M198.1M193.2M
Depreciation and amortization27.1M21.2M20.9M21.1M50.4M64.8M71.6M67.0M
EBITDA153.4M99.0M99.4M150.6M110.6M72.5M111.7M125.4M
EBITDA margin, %37.7%28.6%30.6%35.2%30.0%22.8%29.0%31.3%
EBIT(27.9M)68.7M75.4M142.5M50.0M27.4M39.3M63.9M
EBIT margin, %-6.9%19.8%23.2%33.3%13.6%8.6%10.2%15.9%
Interest income4.8M4.7M2.0M2.0M4.8M8.5M11.3M7.1M
Interest expense776.0K806.0K766.0K755.0K973.0K3.7M3.9M
Pre tax profit123.9M75.5M76.8M139.4M66.3M28.2M64.7M63.7M
Income tax expense25.8M18.3M16.6M29.8M18.8M5.7M17.0M15.7M
Net Income98.1M57.2M60.2M109.6M47.5M22.4M47.8M48.0M

Footer menu